Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

NCT02728531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Bendamustine
DRUG: Rituximab
DRUG: Cytarabine
DRUG: Pegfilgrastim
PROCEDURE: Leukapheresis
DRUG: Filgrastim
PROCEDURE: Autologous stem cell transplant

Sponsor

Washington University School of Medicine